Medical Professionals to Call for the Passage of Medical Cannabis Legislation

Columbia, SC - January 15, 2021 (Investorideas.com Newswire) South Carolina medical professionals will join together on Tuesday for a press conference to call on the legislature to enact a comprehensive medical cannabis program in 2021.

The press conference is being held as momentum to pass a medical cannabis law grows within the legislature. Last month, Sen. Tom Davis (R) and Rep. Bill Herbkersman (R) pre-filed bills that would create a comprehensive medical cannabis program in the state. The South Carolina Compassionate Care Act (S. 150/ H. 3361) would allow patients with debilitating medical conditions and a doctor’s certification to access medical cannabis from regulated facilities.

Thirty-six states across the country have comprehensive medical cannabis programs, including several Southern states, such as Arkansas, Florida, Louisiana, and Virginia. Seventy-three percent of Americans now live in states that allow the medicinal use of cannabis.

What: Medical professionals will call for the passage of S. 150 and H. 3361.

When: Tuesday, January 19, 10 a.m.

Where: Zoom Meeting https://us02web.zoom.us/j/85194802639?pwd=RnJTcTJndk4wMjBoTkovTU1VQUZHQT09

Meeting ID: 851 9480 2639

Passcode: 909075

Who: Rep. Bill Herbkersman

Dr. Jamelah Lemon, president of the S.C. Podiatric Medical Association

Dr. Prakash Nagarkatti, University of South Carolina's Vice President for Research

Dr. Stephen Cutler, Dean, College of Pharmacy, University of South Carolina

Dr. Monnie Singleton, MD, Orangeburg

Pharmacist Daniel Bundrick, Surfside Beach

The South Carolina Compassionate Care Alliance is a statewide coalition of patients, families, and advocates working to establish a comprehensive medical cannabis program in South Carolina. For more information, visit https://www.SCCompassion.com.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Buy a cannabis guest post on Investorideas.com